Tilray Brands, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated June 22, 2023, announces the consummation of the Arrangement between Tilray Brands, Inc. ("Tilray") and HEXO Corp. ("HEXO"). Under the Plan of Arrangement, Tilray acquired all issued and outstanding common and preferred shares of HEXO. The transaction closed on June 22, 2023 (the "Closing Date"), and HEXO voluntarily withdrew its listing from the Nasdaq Stock Market effective at the close of trading on that date.
Key Financial Metrics and Transaction Terms
This filing details the structural terms of the acquisition rather than operating financial results (revenue, profit, or cash flow) for a specific reporting period. Key transaction metrics include:
- Consideration Shares Issued: HEXO shareholders received an aggregate of 39,710,845 shares of Tilray Common Stock.
- Common Exchange Ratio: Each outstanding HEXO common share was exchanged for 0.4352 of a Tilray Common Stock share.
- Preferred Share Exchange: Each outstanding HEXO preferred share was exchanged for 0.7805 of a Tilray Common Stock share.
- Equity Adjustments: Outstanding HEXO equity awards were adjusted or cashed out. Adjusted Options are convertible into an aggregate of 1,283,985 shares of Common Stock.
- Warrant Conversions: Multiple series of HEXO warrants were converted into rights to acquire Tilray Common Stock. The total shares issuable upon exercise of these converted warrants include approximately 8,093 (48North), 99,642 (June 2020), 38,201 (September 2020), 762,844 (August 2021), 30,460 (June 2020), 235,999 (May 2020), and 367,746 (April 2020).
Material Changes Versus Prior Period
The primary material change is the completion of the acquisition of HEXO, resulting in the consolidation of HEXO's operations into Tilray. Consequently, HEXO is no longer a publicly traded independent entity on Nasdaq. The filing does not provide comparative financial performance data (e.g., revenue or EBITDA changes) against prior periods; it focuses on the legal and structural completion of the merger.
Guidance, Outlook, and Material Modifications
Material Modification to Rights of Security Holders: The rights of HEXO security holders were materially modified through the exchange of shares, warrants, and equity awards for Tilray securities or cash.
- Warrant Terms: Exercise prices for converted warrants were adjusted proportionally to the Common Exchange Ratio. For example, the 48North Warrants now have an effective exercise price of C$2,338.58 per whole Tilray share, while the August 2021 HEXO Warrants have an effective exercise price of US$110.98 per whole Tilray share.
- Acceleration Clauses: Several warrant indentures include provisions allowing Tilray to accelerate expiration dates if the Tilray Common Stock price exceeds specific thresholds (e.g., C$4,486.82 for 48North Warrants) for 10 consecutive trading days.
- Equity Awards: HEXO Restricted Share Units (RSUs) and Deferred Share Units (DSUs) were exchanged for cash payments at a value of $1.25 per unit.
Investor Verification Checklist
- Verify the exact number of Tilray shares issued to HEXO shareholders (39,710,845) and the impact on Tilray's total share count.
- Review the specific exercise prices and expiration dates for the converted warrant series, noting the high effective exercise prices resulting from the exchange ratio.
- Confirm the treatment of outstanding HEXO equity awards, specifically the cash payout value ($1.25) for RSUs and DSUs versus the conversion of Options.
- Check the status of the Form S-8 and Form S-3 registration statements referenced for the issuance of shares underlying Adjusted Options and Company Warrants.
- Monitor for potential acceleration of warrant expiration dates if Tilray's stock price meets the specific thresholds outlined in the supplemental indentures.